Sveriges mest populära poddar

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

14 min•12 september 2024

It’s time to talk about mushrooms! Or rather the deadly toxin amanitin found in the death cap mushroom, which Heidelberg Pharma is using as a cancer drug with the help of a tumour-targeting antibody, find out more in this episode featuring Heidelberg Pharma's CEO, Andreas Pahl.

Hosted on Acast. See acast.com/privacy for more information.

Fler avsnitt av Optimum Perspectives

How sleep architecture shapes brain health: new frontiers in Alzheimer’s research

13 mars•20 min

Closing the gap on rare diseases in 2026

26 feb.•19 min

Why who funds science matters

11 feb.•27 min

Tackling the threat of AMR

13 nov. 2025•31 min

The ups and downs of ADCs – where to now?

3 nov. 2025•30 min

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease

5 aug. 2025•23 min

Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025

25 juni 2025•24 min

Stronger together: changing the future of muscle wasting condition

28 feb. 2025•30 min

How bioengineered spider silk-based proteins are changing the world

6 feb. 2025•12 min

How to have a perfect IPO on NASDAQ

23 jan. 2025•24 min

Optimum Perspectives med Optimum Strategic Communications finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.